Richard Finney

Staff Scientist

Biography

Mr. Richard Finney is a staff scientist who supports CBIIT’s Computational Genomics and Bioinformatics Group and provides ongoing bioinformatics support to NCI’s Center for Cancer Research. He developed Chromatic, the Cancer Genome Atlas (TCGA) and open source cancer mutation viewer using WebAssembly technology: https://chromatic.nci.nih.gov. Mr. Finney has published several research papers, most recently including “Chromatic: WebAssembly-based Cancer Genomic View” in the Cancer Informatics journal. He received his bachelor’s degree from the University of Texas at Austin. 

Projects

  • Computational Genomics and Bioinformatics Group
  • Web development: chromatic.nci.nih.gov

Publications

  • Chromatic: WebAssembly-based Cancer Genome Viewer (for journal “Cancer Bioinformatics”, received final acceptance 21 March 2018). 
  • VanderWeele, DJ; Finney, R; Katayama, K et al. Genomic Heterogeneity Within Individual Prostate Cancer Foci Impacts Predictive Biomarkers of Targeted Therapy. Eur Urol Focus, (2018). DOI://10.1016/j.euf.2018.01.006.
  • Transcriptional alterations in hereditary and sporadic nonfunctioning pancreatic neuroendocrine tumors according to genotype.  Cancer. 124(3) (2018):636-647. doi: 10.1002/cncr.31057. Epub 2017, Nov. 17.
  • Discovery analysis of TCGA data reveals association between germline genotype and survival in ovarian cancer patients: PLoS One 8(3) (2013):e55037. doi: 10.1371/journal.pone.0055037. Epub 2013, March 21.
  • Systematic Analysis of Genetic Alterations in Tumors Using Cancer Genome WorkBench (CGWB). Genome Research (2007).
  • Metastasis predictive signature profiles pre-exist in normal tissues. Clinical & Experimental Metastasis 22 (2005): 593–603. 
  • Detecting false expression signals in high-density oligonucleotide arrays by an in silico approach. Genomics 85(3) (2005):297-308
  • A high-resolution multistrain haplotype analysis of laboratory mouse genome reveals three distinctive genetic variation patterns. Genome Res (2005).